In this video, Dr. David Ryan chats with Dr. Inga Lennes, Senior Vice President for Service Excellence and Practice Improvement at the Massachusetts General Physicians Organization, as well as a lung cancer physician at the Mass General Cancer Center.
Inga Lennes, MD, MBA, MPH
Inga Lennes, MD, MBA, MPH
Medical Director, Ambulatory Services, MGH Cancer Center
Director of Clinical Quality, MGH Cancer Center
Departments, Centers, & Programs:
55 Fruit Street
Boston, MA 02114-2696
- MPH, Harvard University
- MBA, Massachusetts Institute of Technology
- MD, UMASS School of Medicine
- MD, University of Massachusetts Medical School
- Residency, Beth Israel Deaconess Medical Center
- Residency, Beth Israel Hospital
- Fellowship, Dana Farber Cancer Institute
- Fellowship, Dana-Farber Cancer Institute
- Fellowship, Dana-Farber/Partners CancerCare
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Quality and safety have been a major theme in my earliest publications to the most recent ones. From defining best practices to determining how to disseminate high-quality oncology care efficiently and effectively; these are the hallmarks of the work that has dominated my administrative and research career.
End of life care is another key focus in my research career. As a member of the Cancer Outcomes Research Group at MGH Cancer Center, I am involved in several projects investigating the drivers of end of life care. One important project in this area was creating a survey to address prognostic awareness and using the tool to understand more about the characteristics of patients with regard to their prognostic understanding.
As a member of an important research team at MGH in thoracic malignancies, I have contributed to research that advances our understanding of lung cancer and served on the NCCN Non-Small Cell Lung Cancer panel, aggregating and interpreting scientific evidence and creating guidelines for the national standard of lung cancer care.
Cancer survivorship is a new and evolving field that spans oncology and primary care medicine. Over the past three years, I have created a data registry to begin collecting important clinical and patient-reported outcomes with regard to cancer survivorship. I have mentored junior researchers who have used the database to conduct scientific inquiries.